Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

617.63

520.02

540.29

475.32

563.56

Operating profit

90.79

65.66

43.27

55.56

119.44

Interest

46.77

44.47

40.07

36.63

42.90

Gross profit

73.66

29.87

25.54

30.59

102.91

EPS (Rs)

5.84

0.28

0.14

0.89

6.91

Other income

29.63

8.69

22.34

11.65

26.38

Stock adjustment

34.09

-36.59

-2.43

9.55

46.76

Raw material

266.45

302.14

288.94

215.10

203.55

Power and fuel

-

-

-

-

-

Employee expenses

86.60

85.66

86.25

76.70

64.53

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

139.71

103.15

124.27

118.40

129.29

Provisions made

-

-

-

-

-

Depreciation

20.81

21.06

21.34

21.46

22.71

Taxation

-0.89

0.98

2.91

1.13

2.80

Net profit / loss

53.66

2.54

1.28

8.00

62.40

Extra ordinary item

-0.07

-5.29

-

-

-15.00

Prior year adjustments

-

-

-

-

-

Equity capital

91.90

91.88

90.30

90.30

90.30

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

14.70

12.63

8.01

11.69

21.19

GPM (%)

11.38

5.65

4.54

6.28

17.44

NPM (%)

8.29

0.48

0.23

1.64

10.58